These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35168479)

  • 1. Patterns of performance of children with neurofibromatosis type 1 on the K-CPT and K-CPT 2.
    Pardej SK; Glad DM; Lee KM; Casnar CL; Klein-Tasman BP
    Child Neuropsychol; 2022 Jul; 28(5):701-708. PubMed ID: 35168479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the Conners' Kiddie Continuous Performance Test (K-CPT) Performance and Parent-Report Measures of Behavior and Executive Functioning.
    Barnard H; Rao R; Xu Y; Froehlich T; Epstein J; Lanphear BP; Yolton K
    J Atten Disord; 2018 Sep; 22(11):1056-1065. PubMed ID: 25846228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parent-Reported Social Skills in Children with Neurofibromatosis Type 1: Longitudinal Patterns and Relations with Attention and Cognitive Functioning.
    Glad DM; Casnar CL; Yund BD; Lee K; Klein-Tasman BP
    J Dev Behav Pediatr; 2021 Oct-Nov 01; 42(8):656-665. PubMed ID: 34618723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance patterns in Conners' CPT among children with attention deficit hyperactivity disorder and dyslexia.
    Miranda MC; Barbosa T; Muszkat M; Rodrigues CC; Sinnes EG; Coelho LF; Rizzuti S; Palma SM; Bueno OF
    Arq Neuropsiquiatr; 2012 Feb; 70(2):91-6. PubMed ID: 22311211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric Properties of Attention Measures in Young Children with Neurofibromatosis Type 1: Preliminary Findings.
    Pardej SK; Lee KM; Glad DM; Klein-Tasman BP
    J Pediatr Neuropsychol; 2022; 8(3):123-136. PubMed ID: 36032331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reading Comprehension Impairment in Children With Neurofibromatosis Type 1 (NF1): The Need of Multimodal Assessment of Attention.
    Biotteau M; Tournay E; Baudou E; Destarac S; Iannuzzi S; Faure-Marie N; Castelnau P; Schweitzer E; Rodriguez D; Kemlin I; Dorison N; Rivier F; Carneiro M; Preclaire E; Barbarot S; Lauwers-Cancès V; Chaix Y
    J Child Neurol; 2021 Jul; 36(8):625-634. PubMed ID: 33507832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining embedded validity indicators in Conners continuous performance test-3 (CPT-3).
    Ord AS; Miskey HM; Lad S; Richter B; Nagy K; Shura RD
    Clin Neuropsychol; 2021 Nov; 35(8):1426-1441. PubMed ID: 32364040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per Se.
    Lion-François L; Herbillon V; Peyric E; Mercier C; Gérard D; Ginhoux T; Coutinho V; Kemlin I; Kassai B; Desportes V; Michael GA
    J Atten Disord; 2020 Nov; 24(13):1807-1823. PubMed ID: 28587546
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous Performance Test II outcomes in 11-year-old children with early ADHD symptoms: a longitudinal study.
    López-Vicente M; Sunyer J; Forns J; Torrent M; Júlvez J
    Neuropsychology; 2014 Mar; 28(2):202-11. PubMed ID: 24364393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a Virtual Classroom environment to describe the attention deficits profile of children with Neurofibromatosis type 1.
    Gilboa Y; Rosenblum S; Fattal-Valevski A; Toledano-Alhadef H; Rizzo AS; Josman N
    Res Dev Disabil; 2011; 32(6):2608-13. PubMed ID: 21757320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relations between fine motor skill and parental report of attention in young children with neurofibromatosis type 1.
    Casnar CL; Janke KM; van der Fluit F; Brei NG; Klein-Tasman BP
    J Clin Exp Neuropsychol; 2014; 36(9):930-43. PubMed ID: 25284746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relations between Continuous Performance Test performance measures and ADHD behaviors.
    Epstein JN; Erkanli A; Conners CK; Klaric J; Costello JE; Angold A
    J Abnorm Child Psychol; 2003 Oct; 31(5):543-54. PubMed ID: 14561061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Behavior Rating Inventory of Executive Function and Continuous Performance Test in Preschoolers with Attention Deficit Hyperactivity Disorder.
    Çak HT; Çengel Kültür SE; Gökler B; Öktem F; Taşkıran C
    Psychiatry Investig; 2017 May; 14(3):260-270. PubMed ID: 28539944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Children with attention deficit/hyperactivity disorder and pervasive developmental disorder:attention and response inhibition in the kiddie continuous performance test].
    Tsushima Y; Sanada S; Yanagihara M; Ohno S; Hirasawa T; Oka M; Ogino T; Ohtsuka Y
    No To Hattatsu; 2011 Sep; 43(5):367-71. PubMed ID: 21941843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ADHD in neurofibromatosis type 1.
    Mautner VF; Kluwe L; Thakker SD; Leark RA
    Dev Med Child Neurol; 2002 Mar; 44(3):164-70. PubMed ID: 12005317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor dysfunction in NF1: Mediated by attention deficit or inherent to the disorder?
    Haas-Lude K; Heimgärtner M; Winter S; Mautner VF; Krägeloh-Mann I; Lidzba K
    Eur J Paediatr Neurol; 2018 Jan; 22(1):164-169. PubMed ID: 29111114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural Dynamics for Facilitating ADHD Diagnosis in Preschoolers: Central and Parietal Delta Synchronization in the Kiddie Continuous Performance Test.
    Chen IC; Chang CH; Chang Y; Lin DS; Lin CH; Ko LW
    IEEE Trans Neural Syst Rehabil Eng; 2021; 29():1524-1533. PubMed ID: 34280103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of ADHD on the cognitive and academic functioning of children with NF1.
    Pride NA; Payne JM; North KN
    Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.
    Morotti H; Mastel S; Keller K; Barnard RA; Hall T; O'Roak BJ; Fombonne E
    Dev Med Child Neurol; 2021 Feb; 63(2):226-232. PubMed ID: 32406525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineating the autistic phenotype in children with neurofibromatosis type 1.
    Chisholm AK; Haebich KM; Pride NA; Walsh KS; Lami F; Ure A; Maloof T; Brignell A; Rouel M; Granader Y; Maier A; Barton B; Darke H; Dabscheck G; Anderson VA; Williams K; North KN; Payne JM
    Mol Autism; 2022 Jan; 13(1):3. PubMed ID: 34983638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.